Persistent elevation of fibrin D-dimer predicts longterm outcome in systemic juvenile idiopathic arthritis

Journal of Rheumatology

Volumn 36, Issue 2, 2009, Pages 422-426

  Bloom, Bradley J ^a,b,c   Alario, Anthony J ^a,b   Miller, Laurie C ^d,e  

^a HASBRO CHILDREN'S HOSPITAL   (United States)

^b BROWN UNIVERSITY   (United States)

^c PFIZER INC   (United States)

^d TUFTS MEDICAL CENTER   (United States)

^e TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Biomarkers; D dimer; Juvenile idiopathic arthritis; Outcome

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOSPORIN A; D DIMER; FIBRIN; IMMUNOGLOBULIN; METHOTREXATE; PREDNISONE; SALAZOSULFAPYRIDINE; BIOLOGICAL MARKER; FIBRIN DEGRADATION PRODUCT; FIBRIN FRAGMENT D;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; CHILD; CLINICAL ARTICLE; DISEASE ACTIVITY; DISEASE CLASSIFICATION; DISEASE MARKER; DISEASE SEVERITY; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; JOINT PROSTHESIS; JUVENILE RHEUMATOID ARTHRITIS; MALE; OUTCOME ASSESSMENT; PREDICTION; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RADIODIAGNOSIS; RISK ASSESSMENT; SCHOOL CHILD; ARTHROGRAPHY; BLOOD; CLINICAL TRIAL; COHORT ANALYSIS; HOSPITALIZATION; IMMUNOLOGY; JOINT; METABOLISM; MULTICENTER STUDY; PATHOLOGY; PREDICTION AND FORECASTING; PROGNOSIS; RETROSPECTIVE STUDY; RISK FACTOR; TREATMENT OUTCOME; UPREGULATION;

ADOLESCENT; ADULT; ARTHRITIS, JUVENILE RHEUMATOID; ARTHROGRAPHY; BIOLOGICAL MARKERS; CHILD; COHORT STUDIES; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; HUMANS; JOINTS; MALE; OUTCOME ASSESSMENT (HEALTH CARE); PREDICTIVE VALUE OF TESTS; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; UP-REGULATION; YOUNG ADULT;

EID: 64849083343     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: 10.3899/jrheum.070600     Document Type: Article

References (33)

1. Cassidy JT, Petty RE. Textbook of pediatric rheumatology. Philadelphia: W.B. Saunders Co.; 2001.
2. Singh-Grewal D, Schneider R, Bayer N, Feldman BM. Predictors of disease course and remission in systemic juvenile idiopathic arthritis. Arthritis Rheum 2006;54:1595-1601
3. Schneider R, Lang BA, Reilly BJ, et al. Prognostic indicators of joint destruction in systemic onset juvenile rheumatoid arthritis. J Pediatr 1992;120:200-205
4. Spiegel LR, Schneider R, Lang BA, et al. Early predictors of poor functional outcome in systemic onset juvenile rheumatoid arthritis. Arthritis Rheum 2000;43:2402-2409
5. Sandborg C, Holmes TH, Lee T, et al. Candidate early predictors for progression to joint damage in systemic juvenile idiopathic arthritis. J Rheumatol 2006;33:2322-2329 (Pubitemid 44749796)
6. Bowyer SL, Ragsdale CG, Sullivan DB. Factor VIII related antigen and childhood rheumatic disease. J Rheumatol 1989;16:1093-1097 (Pubitemid 19234738)
7. Scott JP, Gerber P, Maryjowski MC, et al. Evidence for intravascular coagulation in systemic onset, but not polyarticular, juvenile rheumatoid arthritis. Arthritis Rheum 1985;28:256-261 (Pubitemid 15133569)
8. Inamo Y, Pemberton S, Tuddenham EGD, Woo P. Increase of activated factor VIIA and haemostatic molecular markers in juvenile chronic arthritis. Br J Rheumatol 1995;34:466-469
9. Bloom BJ, Nelson SM, Eisenberg D, Alario AJ. Soluble ICAM-1 and E-selectin as markers of disease activity and endothelial activation in juvenile rheumatoid arthritis. J Rheumatol 2005;32:366-372 (Pubitemid 40209139)
10. Gallistl S, Mangge H, Neuwirth G, Muntean W. Activation of the haemostatic system in children with juvenile rheumatoid arthritis correlates with disease activity. Thromb Res 1998;92:267-272 (Pubitemid 29012770)
11. Busso N, Hamilton JA. Extravascular coagulation and the plasminogen activator/plasmin system in rheumatoid arthritis. Arthritis Rheum 2002;46:2268-2279
12. DeBenedetti F, Pignatti P, Massa M, et al. Soluble tumor necrosis factor receptor levels reflect coagulation abnormalities in systemic juvenile chronic arthritis. Br J Rheumatol 1997;36:581-588 (Pubitemid 27344493)
13. Laucella SA, Gaddi E, Balbaryski J, et al. Soluble intercellular adhesion molecule-l in paediatric connective tissue diseases. Acta Paediatrica 1999;88:399-403. (Pubitemid 29211286)
14. Chen CY, Tsao CH, Ou LS, et al. Comparison of soluble adhesion molecules in juvenile idiopathic arthritis between the active and remission stages. Ann Rheum Dis 2002;61:167-170 (Pubitemid 34098434)
15. Bloom BJ, Tucker LB, Miller LC, Schaller JG. Fibrin d-dimer as a marker of disease activity in systemic onset juvenile rheumatoid arthritis. J Rheumatol 1998;25:1620-1625 (Pubitemid 28364772)
16. Hashkes PJ, Laxer RM. Medical treatment of juvenile idiopathic arthritis. JAMA 2005;294:1671-1684 (Pubitemid 41407360)
17. Malleson PN. Pharmacological treatment of early or established arthritis. In: Szer IS, Kimura Y, Malleson PN, Southwood TR, editors. Arthritis in children and adolescents. New York: Oxford University Press; 2006:367-380
18. Wallace CA, Ruperto N, Giannini EH. Preliminary criteria for clinical remission for select categories of juvenile idiopathic arthritis. J Rheumatol 2004;31:2290-2294 (Pubitemid 39453253)
19. Bloom BJ, Nelson SM, Alario AJ, Miller LC, Schaller JG. Synovial fluid levels of E-selectin and ICAM-1: relationship to joint inflammation in children with chronic arthritis. Rheumatol Int 2002;22:175-177
20. Bloom BJ, Toyoda M, Petrosian A, Jordan S. Anti-endothelial cell antibodies are prevalent in juvenile idiopathic arthritis: implications for clinical disease course and pathogenesis. Rheumatol Int 2007;27:655-660 (Pubitemid 46625352)
21. Tripathy NK, Sinha N, Nityanand S. Anti-annexin antibodies in Takayasu's arteritis: prevalence and relationship with disease activity. Clin Exp Immunol 2003;134:360-364 (Pubitemid 37372290)
22. Blank M, Krause I, Goldkorn T, et al. Monoclonal anti-endothelial cell antibodies from a patient with Takayasu arteritis activate endothelial cells from large vessels. Arthritis Rheum 1999;42:1421-1432 (Pubitemid 30265600)
23. Damianovich M, Gilburd B, George J, et al. Pathogenic role of anti-endothelial cell antibodies in vasculitis. An idiotypic experimental model. J Immunol 1996;156:4946-4951 (Pubitemid 26174484)
24. Madson KL, Moore TL, Lawrence JM, Osborn TG. Cytokine levels in serum and synovial fluid of patients with juvenile rheumatoid arthritis. J Rheumatol 1994;21:2359-2363
25. Rooney M, David J, Symons J, et al. Inflammatory cytokine responses in juvenile chronic arthritis. Br J Rheumatol 1995;34:454-460
26. Mannge H, Kenzian H, Gallistl S, et al. Serum cytokines in juvenile rheumatoid arthritis. Arthritis Rheum 1995;38:211-220
27. So AK, Varisco PA, Kemkes-Matthes B, et al. Arthritis is linked to local and systemic activation of coagulation and fibrinolysis pathways. J Thromb Haemost 2003;1:2510-2515
28. Bevilacqua MP, Pober JS, Majeau GR, et al. Interleukin-1 (IL-1) induces biosynthesis and cell surface expression of procoagulant activity in human vascular endothelial cells. J Exp Med 1984;160:618-623 (Pubitemid 14052522)
29. Szotowski B, Antoniak S, Poller W, Schultheiss HP, Rauch U. Procoagulant soluble tissue factor is released from endothelial cells in response to inflammatory cytokines. Circ Res 2005;96:1233-1239 (Pubitemid 40962100)
30. Lovell DJ, Giannini EH, Kimura Y, et al. Preliminary evidence for bioactivity of IL-1 inhibitor, in systemic juvenile idiopathic arthritis (SJIA) [abstract]. Arthritis Rheum 2006;55 Suppl:S718.
31. Poznanski AK, Hernandez RJ, Guire KE, Bereza U, Garn SM. Carpal length in children: a useful measurement in the diagnosis of rheumatoid arthritis and some congenital malformation syndromes. Radiology 1978;129:661-668 (Pubitemid 9059971)
32. Rossi F, Di Dia F, Galipo O, et al. Use of the Sharp and Larsen scoring methods in the assessment of radiographic progression in juvenile idiopathic arthritis. Arthritis Care Res 2006;55:717-723 (Pubitemid 44619184)
33. Lang BA, Schneider R, Reilly BJ, Silverman ED, Laxer RM. Radiologic features of systemic onset juvenile rheumatoid arthritis. J Rheumatol 1995;22:168-173